Stephanie Roland

Stephanie Roland possesses extensive experience in regulatory affairs, currently serving as Executive Director of Regulatory Affairs at Intercept Pharmaceuticals since January 2024. Prior to this role, Stephanie held the position of Vice President of Regulatory Affairs at Imago BioSciences, Inc. from June 2022 to July 2023, and at AZTherapies, Inc. from November 2020 to May 2022. Additional roles include Director at Clinipace from February 2017 to November 2020 and Associate Director positions at Nivalis Therapeutics, Inc. and Clinipace Worldwide. Stephanie's career also includes regulatory positions at Sandoz, Array BioPharma, sanofi-aventis, and CorePharma LLC, showcasing a robust background in the pharmaceutical industry.